Table 3.
Medication use among subjects with diverticulosis and subjects without diverticulosis
| Medications | Subjects with diverticulosis | Subjects without diverticulosis | P values |
|---|---|---|---|
| Proton pump inhibitors | 59/99 (58.5%) | 78/164 (47.5%) | 0.083 |
| Antihypertensive medications | 46/99 (46.4%) | 42/164 (25.6%) | 0.001 |
| Psychiatric medications | 34/99 (34.3%) | 44/164 (26.8%) | 0.196 |
| Vitamin supplements | 32/99 (32.3%) | 44/164 (26.8%) | 0.341 |
| Cardiovascular medications | 31/99 (31.3%) | 38/164 (23.1%) | 0.146 |
| NSAIDs | 30/99 (30.3%) | 35/164 (21.3%) | 0.103 |
| Anticholinergics | 24/99 (24.2%) | 33/164 (20.1%) | 0.432 |
| Previous use of antibiotics | 24/99 (24.2%) | 32/164 (19.5%) | 0.364 |
| Stool softeners | 22/99 (22.2%) | 22/164 (13.4%) | 0.064 |
| Pulmonary and allergy | 21/99 (21.2%) | 33/164 (20.1%) | 0.832 |
| Diabetes medications | 19/99 (19.1%) | 18/164 (10.9%) | 0.063 |
| Other neurological medications | 17/99 (17.1%) | 26/164 (15.8%) | 0.779 |
| Thyroid medications | 15/99 (15.1%) | 20/164 (12.1%) | 0.494 |
| IBS medications | 14/99 (14.1%) | 28/164 (17.07%) | 0.529 |
| Immunosuppresants | 12/99 (12.1%) | 15/164 (9.01%) | 0.441 |
| Corticosteroids | 9/99 (9.09%) | 17/164 (10.3%) | 0.737 |
| H2Blockers | 7/83 (8.4%) | 18/127 (14.1%) | 0.209 |
| Narcotics | 8/98 (8.1%) | 12/164 (7.3%) | 0.803 |
| Other antacids | 6/99 (6.06%) | 14/164 (8.5%) | 0.463 |
| Prokinetics | 5/99 (5.05%) | 14/164 (8.5%) | 0.290 |
| Iron supplements | 4/99 (4.04%) | 10/164 (6.09%) | 0.472 |
| Anticonvulsants | 4/99 (4.04%) | 4/164 (2.43%) | 0.464 |
NSAIDs, non-steroidal anti-inflammatory drugs; IBS, irritable bowel syndrome.